Oral agents offer glycemic control, improved beta-cell function in severe hyperglycemia

The combination DPP-IV inhibitor plus metformin Kombiglyze XR was as effective as glipizide XL in lowering blood glucose and improving beta-cell function in patients with newly diagnosed type-2 diabetes and severe hyperglycemia, according to recently published results in JCEM. Healio
Source: Society for Endocrinology - Category: Endocrinology Source Type: news